[Congressional Record Volume 161, Number 88 (Wednesday, June 3, 2015)]
[Senate]
[Page S3712]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SA 1560. Mr. BLUMENTHAL (for himself and Mr. Durbin) submitted an
amendment intended to be proposed to amendment SA 1463 proposed by Mr.
McCain to the bill H.R. 1735, to authorize appropriations for fiscal
year 2016 for military activities of the Department of Defense and for
military construction, to prescribe military personnel strengths for
such fiscal year, and for other purposes; which was ordered to lie on
the table; as follows:
At the end of subtitle B of title VII, add the following:
SEC. 721. MONITORING OF ADVERSE EVENT DATA ON DIETARY
SUPPLEMENT USE BY MEMBERS OF THE ARMED FORCES.
(a) In General.--The Secretary of Defense shall modify the
electronic health record system of the military health system
to include data regarding the use by members of the Armed
Forces of dietary supplements and adverse events with respect
to dietary supplements.
(b) Requirements.--The modifications required by subsection
(a) shall ensure that the electronic health record system of
the military health system--
(1) records adverse event report data regarding dietary
supplement use by members of the Armed Forces;
(2) generates standard reports on adverse event data that
can be aggregated for analysis;
(3) issues automated alerts to signal a significant change
in adverse event reporting or to signal a risk of interaction
with a medication or other treatment; and
(4) is interoperable with the MedWatch form of the Food and
Drug Administration (as described in section 760(d) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379aa(d))).
(c) Outreach.--The Secretary shall conduct outreach to
health care providers in the military health system to
educate such providers on the importance of entering adverse
event report data regarding dietary supplement use by members
of the Armed Forces into the electronic health record system
of the military health system and the MedWatch form described
in subsection (b)(4).
(d) Definitions.--In this section:
(1) Adverse event.--The term ``adverse event'' has the
meaning given such term in section 761(a) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 379aa-1(a)).
(2) Dietary supplement.--The term ``dietary supplement''
has the meaning given such term in section 201(ff) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(ff)).
______